Research Paper (60)

  • Shedding light on the dark genome: drugging long non-coding RNA
    Shedding light on the dark genome: drugging long non-coding RNA

    Stefan Schiesser

    Get Access
  • The case for cancer-associated fibroblasts: essential elements in cancer drug discovery?
    The case for cancer-associated fibroblasts: essential elements in cancer drug discovery?

    Gabrielle Brewer

    Get Access
  • Overcoming the shortcomings of peptide-based therapeutics
    Overcoming the shortcomings of peptide-based therapeutics

    Christina Lamers

    Get Access
  • The possible drug for cancer and metastasis prevention
    The possible drug for cancer and metastasis prevention

    Vladimir N Pak

    Get Access
  • Breakthrough medicines during the COVID-19 pandemic era
    Breakthrough medicines during the COVID-19 pandemic era

    Eswara Naga Hanuma Kumar Ghali

    Get Access
  • Interview with Hunterian CEO Dr Vinod Jaskula-Ranga
    Interview with Hunterian CEO Dr Vinod Jaskula-Ranga

    Vinod Jaskula-Ranga

    Get Access
  • miRNA-205: a future therapeutic molecule for liver diseases
    miRNA-205: a future therapeutic molecule for liver diseases

    Marco Cabrera

    Get Access
  • Quo vadis artificial intelligence and personalized medicine?
    Quo vadis artificial intelligence and personalized medicine?

    Antonio J Banegas-Luna

    Get Access
  • Role of pharmaceutical sciences in future drug discovery
    Role of pharmaceutical sciences in future drug discovery

    Srinivasa Reddy Bonam

    Get Access
  • The role of immunotherapy in treating lung cancer: current status and future perspective
    The role of immunotherapy in treating lung cancer: current status and future perspective

    Carlton Bijesh Ray

    Get Access
  • COVID-19 vaccines: challenges and promises of trials, manufacturing and allocation of doses
    COVID-19 vaccines: challenges and promises of trials, manufacturing and allocation of doses

    Benedetta Spadaro

    Get Access
  • High-throughput approaches of diagnosis and therapies for COVID-19: antibody panels, proteomics and metabolomics
    High-throughput approaches of diagnosis and therapies for COVID-19: antibody panels, proteomics and metabolomics

    Rwik Sen

    Get Access
  • Is it time to look beyond bronchodilators and corticosteroids in treating COPD?
    Is it time to look beyond bronchodilators and corticosteroids in treating COPD?

    Mario Cazzola

    Get Access
  • Melanie Leveridge on ELRIG and a career in drug discovery
    Melanie Leveridge on ELRIG and a career in drug discovery

    Melanie Leveridge

    Get Access
  • Evaluation of potential anti-COVID-19 therapies
    Evaluation of potential anti-COVID-19 therapies

    Clare L Box

    Get Access
  • Artificial intelligence in drug design: algorithms, applications, challenges and ethics
    Artificial intelligence in drug design: algorithms, applications, challenges and ethics

    Alya A Arabi

    Get Access
  • Welcome to Volume 3 of Future Drug Discovery
    Welcome to Volume 3 of Future Drug Discovery

    Francesca Lake

    Get Access
  • Computational approaches to targeting protein–protein interactions in cancer: a pathway to drug discovery
    Computational approaches to targeting protein–protein interactions in cancer: a pathway to drug discovery

    Melody Okereke

    Get Access
  • Targeting immune checkpoint pathways in melanoma: triumphs and challenges
    Targeting immune checkpoint pathways in melanoma: triumphs and challenges

    Patricia Ines Back

    Get Access
  • Development of a novel chemoinformatic tool for natural product databases
    Development of a novel chemoinformatic tool for natural product databases

    Paulo Ricardo Viviurka do Carmo

    Get Access
  • Codeine dysregulates ribosome biogenesis in Escherichia coli with DNA double-strand breaks to chart path to new classes of antibiotics
    Codeine dysregulates ribosome biogenesis in Escherichia coli with DNA double-strand breaks to chart path to new classes of antibiotics

    Vincent Amarh

    Get Access
  • Recent advances in small molecular modulators targeting histone deacetylase 6
    Recent advances in small molecular modulators targeting histone deacetylase 6

    Yufeng Xiao

    Get Access
  • Academia versus industry: choosing a career in drug discovery
    Academia versus industry: choosing a career in drug discovery

    Sarah J Caswell

    Get Access
  • Immuno-oncology: developing integrated approaches toward clinical success of biologics and small-molecule modulators
    Immuno-oncology: developing integrated approaches toward clinical success of biologics and small-molecule modulators

    Shilina Roman

    Get Access
  • Modeling the heart with Novoheart’s MyHeart™ platform
    Modeling the heart with Novoheart’s MyHeart™ platform

    Gabriel K Y Wong

    Get Access
  • Measurement of macro- and micro-heterogeneity of glycosylation in biopharmaceuticals: a pharmacopeia perspective
    Measurement of macro- and micro-heterogeneity of glycosylation in biopharmaceuticals: a pharmacopeia perspective

    Jingzhong Guo

    Get Access
  • Drug repurposing patent documents vs peer review: patent information comes more than 600 days earlier on average
    Drug repurposing patent documents vs peer review: patent information comes more than 600 days earlier on average

    Hermann Mucke

    Get Access
  • Peptide drugs for photopharmacology: how much of a safety advantage can be gained by photocontrol?
    Peptide drugs for photopharmacology: how much of a safety advantage can be gained by photocontrol?

    Oleg Babii

    Get Access
  • Role of neuraxial drug delivery in cancer pain therapy
    Role of neuraxial drug delivery in cancer pain therapy

    Edgar Ross

    Get Access
  • Deep SAR matrix: SAR matrix expansion for advanced analog design using deep learning architectures
    Deep SAR matrix: SAR matrix expansion for advanced analog design using deep learning architectures

    Atsushi Yoshimori

    Get Access

Your Feedback